Vivos (RDGL) Return on Sales (QoQ) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vivos | - | - | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 226.00 |
| Sep 30, 2025 | -227.00 |
| Jun 30, 2025 | -12.00 |
| Mar 31, 2025 | 174.00 |
| Dec 31, 2024 | -40.00 |
| Sep 30, 2024 | -128.00 |
| Jun 30, 2024 | 87.00 |
| Mar 31, 2024 | 24.00 |
| Dec 31, 2023 | -53.00 |
| Sep 30, 2023 | 43.00 |
| Jun 30, 2023 | -97.00 |
| Mar 31, 2023 | 67.00 |
| Dec 31, 2022 | -66.00 |
| Sep 30, 2022 | 32.00 |
| Jun 30, 2022 | -21.00 |
| Mar 31, 2022 | 62.00 |
| Dec 31, 2021 | -102.00 |
| Dec 31, 2020 | -39.00 |
| Dec 31, 2019 | -252.00 |
| Mar 31, 2018 | 1,532.00 |
| Dec 31, 2017 | -719.00 |
| Sep 30, 2017 | -642.00 |
| Jun 30, 2017 | -119.00 |
| Mar 31, 2017 | 707.00 |
| Dec 31, 2016 | -772.00 |
| Sep 30, 2016 | 993.00 |
| Jun 30, 2016 | 400.00 |
| Mar 31, 2016 | -1,691.00 |
| Dec 31, 2015 | 468.00 |
| Sep 30, 2015 | 424.00 |
| Jun 30, 2015 | -765.00 |
| Mar 31, 2015 | 882.00 |
| Dec 31, 2014 | -567.00 |
| Sep 30, 2014 | -61.00 |
| Jun 30, 2014 | -46.00 |
| Mar 31, 2014 | -52.00 |
| Dec 31, 2013 | -16.00 |
| Sep 30, 2013 | 40.00 |
| Jun 30, 2013 | -24.00 |
| Mar 31, 2013 | 35.00 |
| Dec 31, 2012 | -23.00 |
| Sep 30, 2012 | 12.00 |
| Jun 30, 2012 | -32.00 |
| Mar 31, 2012 | 0.00 |
| Dec 31, 2011 | -5.00 |
| Sep 30, 2011 | 4.00 |
| Jun 30, 2011 | -3.00 |
| Mar 31, 2011 | -9.00 |